Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
暂无分享,去创建一个
W. Chung | R. Finkel | E. Bertini | M. Schroth | A. Simonds | M. Main | T. Crawford | B. Wirth | E. Mazzone | E. Mercuri | F. Muntoni | L. Miladi | C. Reilly | T. Sejersen | E. Tizzano | S. Iannaccone | F. Tiziano | K. Swoboda | K. Krosschell | Shou‐Mei Wu | J. Dubousset | S. Quijano-roy | K. Foust | H. Topaloglu | J. Montes | H. Roper | P. Sponseller | M. Vitale | C. Hasler | K. Rose | S. Woods | C. Vuillerot | J. Kirschner | Leslie Nelson | M. Halanski | A. Stępień | M. Yazici | L. Rodan | Lance H Rodan | B. Roye | R. Graham | S. Barja | A. Glanzman | R. Gee | A. Szlagatys-Sidorkiewicz | A. Kroksmark | T. Prior | Rebecca Hurst Davis | D. Farrington | Stacey Tarrant | Jack Flynn | K. Swoboda | T. Crawford | Y. Qian | E. Seffrood | Oscar H. Meyer | B. Snyder | N. Laing | S. Kayoko | Caron Coleman | R. Hurst | S. Bertoli | B. Kyle | H. Topaloğlu
[1] R. Finkel,et al. 218th ENMC International Workshop: Revisiting the consensus on standards of care in SMA Naarden, The Netherlands, 19–21 February 2016 , 2017, Neuromuscular Disorders.
[2] R. Finkel,et al. Stakeholder collaboration for spinal muscular atrophy therapy development , 2017, The Lancet Neurology.
[3] G. La Rosa,et al. Magnetically Controlled Growing Rods for the Management of Early-onset Scoliosis: A Preliminary Report , 2017, Journal of pediatric orthopedics.
[4] R. Finkel,et al. Spinal Muscular Atrophy Type I , 2017, Journal of child neurology.
[5] A. Beaudet,et al. The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing , 2017, Genetics in Medicine.
[6] R. Finkel,et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study , 2016, The Lancet.
[7] L. Miladi,et al. Prevention and treatment of scoliosis by Garches Brace in children with type Ib SMA , 2016 .
[8] N. Figueiredo,et al. The use of magnetically controlled growing rod device for pediatric scoliosis , 2016, Neurosciences.
[9] R. Finkel,et al. Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials , 2015, Neuromuscular Disorders.
[10] K. Swoboda,et al. Responses to Fasting and Glucose Loading in a Cohort of Well Children with Spinal Muscular Atrophy Type II. , 2015, The Journal of pediatrics.
[11] E. Bertini,et al. Orthopedic Management of Scoliosis by Garches Brace and Spinal Fusion in SMA Type 2 Children , 2015, Journal of neuromuscular diseases.
[12] J. Montes,et al. Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative? , 2015, Journal of neuromuscular diseases.
[13] B. Ilharreborde,et al. Fusionless surgery in early-onset scoliosis. , 2015, Orthopaedics & traumatology, surgery & research : OTSR.
[14] J. Carey,et al. Resistance strength training exercise in children with spinal muscular atrophy , 2015, Muscle & nerve.
[15] K. Baldwin,et al. Neuromuscular scoliosis and pelvic fixation in 2015: Where do we stand? , 2015, World journal of orthopedics.
[16] J. Vissing,et al. Training improves oxidative capacity, but not function, in spinal muscular atrophy type III , 2015, Muscle & nerve.
[17] B. Snyder,et al. Parasol Rib Deformity in Hypotonic Neuromuscular Scoliosis: A New Radiographical Definition and a Comparison of Short-term Treatment Outcomes With VEPTR and Growing Rods , 2015, Spine.
[18] G. Comi,et al. Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy. , 2015, JAMA neurology.
[19] M. Schroth,et al. Nutritional Practices at a Glance , 2014, Journal of child neurology.
[20] W. Chung,et al. Observational study of spinal muscular atrophy type I and implications for clinical trials , 2014, Neurology.
[21] F. Muntoni,et al. Improvement of Pulmonary Function in Children With Early-Onset Scoliosis Using Magnetic Growth Rods , 2014, Spine.
[22] M. Gurney,et al. The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice , 2014, Experimental Neurology.
[23] Kristine C. Jordan,et al. Vitamin D Intake Is Inadequate in Spinal Muscular Atrophy Type I Cohort , 2014, Journal of child neurology.
[24] M. Bowerman,et al. Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology , 2014, Human molecular genetics.
[25] K. Swoboda,et al. Perceptions of Equine-Assisted Activities and Therapies by Parents and Children With Spinal Muscular Atrophy , 2014, Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association.
[26] G. Haaker,et al. The Application of Clinical Genetics Dovepress Proximal Spinal Muscular Atrophy: Current Orthopedic Perspective , 2022 .
[27] J. Forst,et al. Natural course of scoliosis in proximal spinal muscular atrophy type II and IIIa: descriptive clinical study with retrospective data collection of 126 patients , 2013, BMC Musculoskeletal Disorders.
[28] M. Main,et al. Six minute walk test in type III spinal muscular atrophy: A 12month longitudinal study , 2013, Neuromuscular Disorders.
[29] R. Écochard,et al. Responsiveness of the motor function measure in patients with spinal muscular atrophy. , 2013, Archives of physical medicine and rehabilitation.
[30] J. Bach,et al. Posterior Spinal Fusion in Children With Flaccid Neuromuscular Scoliosis: The Role of Noninvasive Positive Pressure Ventilatory Support , 2013, Journal of pediatric orthopedics.
[31] Petra Kaufmann,et al. Independent Mobility After Early Introduction of a Power Wheelchair in Spinal Muscular Atrophy , 2013, Journal of child neurology.
[32] R. Stockley,et al. It’s more than just physical therapy: reported utilization of physiotherapy services for adults with neuromuscular disorders attending a specialist centre , 2013, Disability and rehabilitation.
[33] H. Noordeen,et al. Early results of a remotely-operated magnetic growth rod in early-onset scoliosis. , 2013, The bone & joint journal.
[34] K. Swoboda,et al. Observational study of caloric and nutrient intake, bone density, and body composition in infants and children with spinal muscular atrophy type I , 2012, Neuromuscular Disorders.
[35] W. Chung,et al. Prospective cohort study of spinal muscular atrophy types 2 and 3 , 2012, Neurology.
[36] J. Forst,et al. Operative treatment of scoliosis in proximal spinal muscular atrophy: results of 41 patients , 2012, Archives of Orthopaedic and Trauma Surgery.
[37] C. McDonald,et al. Prevention and management of limb contractures in neuromuscular diseases. , 2012, Physical medicine and rehabilitation clinics of North America.
[38] M. Bowerman,et al. Glucose metabolism and pancreatic defects in spinal muscular atrophy , 2012, Annals of neurology.
[39] A. Leet,et al. Spinal Muscular Atrophy: Manifestations and Management , 2012, The Journal of the American Academy of Orthopaedic Surgeons.
[40] Dino Samartzis,et al. Magnetically controlled growing rods for severe spinal curvature in young children: a prospective case series , 2012, The Lancet.
[41] E. Bertini,et al. Childhood spinal muscular atrophy: controversies and challenges , 2012, The Lancet Neurology.
[42] Y. Jong,et al. Prevalence and risk factors for feeding and swallowing difficulties in spinal muscular atrophy types II and III. , 2012, The Journal of pediatrics.
[43] P. Huddleston. Growing Rods for Scoliosis in Spinal Muscular Atrophy: Structural Effects, Complications, and Hospital Stays , 2012 .
[44] J. Yang,et al. Surgical Correction of Paralytic Neuromuscular Scoliosis With Poor Pulmonary Functions , 2011, Journal of spinal disorders & techniques.
[45] W. Chung,et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. , 2011, Archives of neurology.
[46] R. Finkel,et al. Assessing upper limb function in nonambulant SMA patients: Development of a new module , 2011, Neuromuscular Disorders.
[47] J. McCarthy,et al. Early Treatment of Scoliosis With Growing Rods in Children With Severe Spinal Muscular Atrophy: A Preliminary Report , 2011, Journal of pediatric orthopedics.
[48] J. Forst,et al. Use of orthoses and orthopaedic technical devices in proximal spinal muscular atrophy. Results of survey in 194 SMA patients , 2011, Disability and rehabilitation. Assistive technology.
[49] J. Forst,et al. Contractures of the lower extremities in spinal muscular atrophy type II. Descriptive clinical study with retrospective data collection. , 2011, Ortopedia, traumatologia, rehabilitacja.
[50] Yasser Salem,et al. Aquatic Therapy for a Child with Type III Spinal Muscular Atrophy: A Case Report , 2010, Physical & occupational therapy in pediatrics.
[51] M. Schroth,et al. SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy , 2010, PloS one.
[52] J. Montes,et al. Bioelectrical Impedance Analysis Can Be a Useful Screen for Excess Adiposity in Spinal Muscular Atrophy , 2010, Journal of child neurology.
[53] W. Chung,et al. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy , 2010, Neurology.
[54] R. Finkel,et al. The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability , 2010, Neuromuscular Disorders.
[55] J. Forst,et al. Contractures of the upper extremities in spinal muscular atrophy type II. Descriptive clinical study with retrospective data collection. , 2010, Ortopedia, traumatologia, rehabilitacja.
[56] C. Lorson,et al. Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy. , 2010, Biochemical and biophysical research communications.
[57] E. Bertini,et al. SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR , 2010, European Journal of Human Genetics.
[58] R. Quinlivan,et al. Implementation of “the consensus statement for the standard of care in spinal muscular atrophy” when applied to infants with severe type 1 SMA in the UK , 2009, Archives of Disease in Childhood.
[59] B. Maria,et al. Bone loss in survival motor neuron (Smn−/− SMN2) genetic mouse model of spinal muscular atrophy , 2009, The Journal of pathology.
[60] D. Skaggs,et al. Pelvic Fixation of Growing Rods: Comparison of Constructs , 2009, Spine.
[61] D. Vivo,et al. Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy , 2009, Neuromuscular Disorders.
[62] M. Schroth,et al. Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy , 2009, PloS one.
[63] N. Darín,et al. A population‐based study of genotypic and phenotypic variability in children with spinal muscular atrophy , 2009, Acta paediatrica.
[64] L. Boitano. Equipment Options for Cough Augmentation, Ventilation, and Noninvasive Interfaces in Neuromuscular Respiratory Management , 2009, Pediatrics.
[65] M. Schroth,et al. Early laparoscopic fundoplication and gastrostomy in infants with spinal muscular atrophy type I. , 2008, Journal of pediatric surgery.
[66] Barrington G. Burnett,et al. Sustained improvement of spinal muscular atrophy mice treated with trichostatin a plus nutrition , 2008, Annals of neurology.
[67] S. Iannaccone,et al. Low Bone Mineral Density in Spinal Muscular Atrophy , 2008, Journal of clinical neuromuscular disease.
[68] Mitchell R Lunn,et al. Spinal muscular atrophy , 2008, The Lancet.
[69] P. D. Rose,et al. Feeding problems and malnutrition in spinal muscular atrophy type II , 2008, Neuromuscular Disorders.
[70] G. Levy,et al. The changing natural history of spinal muscular atrophy type 1 , 2007, Neurology.
[71] Ching H. Wang,et al. Consensus Statement for Standard of Care in Spinal Muscular Atrophy , 2007, Journal of child neurology.
[72] B. Maria,et al. Congenital Bone Fractures in Spinal Muscular Atrophy: Functional Role for SMN Protein in Bone Remodeling , 2007, Journal of child neurology.
[73] M. Leavitt,et al. Department of Health and Human Services , 2007, Disaster Medicine and Public Health Preparedness.
[74] B. Wirth,et al. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number , 2006, Human Genetics.
[75] Tanvir R. Khan,et al. Operative treatment for hip subluxation in spinal muscular atrophy. , 2005, The Journal of bone and joint surgery. British volume.
[76] Mark B Bromberg,et al. Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function , 2005, Annals of neurology.
[77] J. Forst,et al. Treatment of scoliosis in intermediate spinal muscular atrophy (SMA type II) in childhood. , 2005, Ortopedia, traumatologia, rehabilitacja.
[78] M. Muqit,et al. Phenotypic variability in siblings with type III spinal muscular atrophy , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[79] Sing Kai Lo,et al. Joint range of motion limitations in children and young adults with spinal muscular atrophy. , 2004, Archives of physical medicine and rehabilitation.
[80] R. Shiffman,et al. Classifying Recommendations for Clinical Practice Guidelines , 2004, Pediatrics.
[81] Jhp Hui,et al. Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III , 2003, Journal of paediatrics and child health.
[82] J. Vissing,et al. Patients with severe muscle wasting are prone to develop hypoglycemia during fasting , 2003, Neurology.
[83] R. Truog,et al. Spinal muscular atrophy–type I , 2003, Archives of disease in childhood.
[84] Brian G Smith,et al. Hip dislocation in patients with spinal muscular atrophy. , 2003 .
[85] T. Wienker,et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. , 2002, American journal of human genetics.
[86] S. Reddy,et al. Osteoclast-stimulating Factor Interacts with the Spinal Muscular Atrophy Gene Product to Stimulate Osteoclast Formation* , 2001, The Journal of Biological Chemistry.
[87] B. Wirth. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA) , 2000, Human mutation.
[88] T. Wienker,et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. , 1999, American journal of human genetics.
[89] T. Crawford,et al. Abnormal fatty acid metabolism in childhood spinal muscular atrophy , 1999, Annals of neurology.
[90] B. Wirth,et al. De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. , 1997, American journal of human genetics.
[91] L. Simard,et al. SMN(T) and NAIP mutations in Canadian families with spinal muscular atrophy (SMA): genotype/phenotype correlations with disease severity. , 1997, American journal of medical genetics.
[92] A. Burghes. When is a deletion not a deletion? When it is converted. , 1997, American journal of human genetics.
[93] J. Mendell,et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. , 1997, American journal of human genetics.
[94] A. Oliveira,et al. Spinal muscular atrophy type II (intermediary) and III (Kugelberg-Welander). Evolution of 50 patients with physiotherapy and hydrotherapy in a swimming pool. , 1996, Arquivos de neuro-psiquiatria.
[95] E. Velasco,et al. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. , 1996, Human molecular genetics.
[96] J. Kondrup,et al. Hypogkycaemia in spinal muscular atrophy , 1995, The Lancet.
[97] K. Davies,et al. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. , 1995, Human molecular genetics.
[98] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.
[99] J. Kondrup,et al. Hypoglycaemia in spinal muscular atrophy. , 1995, Lancet.
[100] D. Millington,et al. Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)? , 1995, Pediatric neurology.
[101] A. Leet,et al. Surgical Treatment of Scoliosis in a Spinal Muscular Atrophy Population , 1990, Spine.
[102] C Schofield,et al. An annotated bibliography of source material for basal metabolic rate data. , 1985, Human nutrition. Clinical nutrition.
[103] David H. Gustafson,et al. Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes , 1976 .